Analgesics

Euromonitor is excited to introduce the OTC e-commerce index, a resource to help OTC drug manufacturers determine the sales growth potential for various OTC products through e-commerce. When evaluating e-commerce opportunities, not all OTC products ...

Internet retailing is the fastest growing distribution channel for OTC consumer health products worldwide. Consumers are increasingly moving toward the use of digital platforms for convenience and speed in delivery, which fit consumers’ busy lives. ...

The analgesics market in Western Europe was overtaken as the second largest global region for sales by Asia Pacific in 2011, and continues to grow only slowly, faced with relatively static national markets and a consumer base that increasingly shies ...

Because of its easy accessibility and painkilling effect for light, undiagnosed ailment and pains, analgesics remains the largest OTC category in Nigeria in value sales terms. Growth is driven by the increasing urban population, among whom many work ...

The rising health awareness of many Taiwanese consumers is having a negative influence on demand for analgesics and this is because people are becoming more cautious about the medicines they take and the long-term side effects of these medicines. As ...

Consumer Health ended 2017 in flux, with growth in OTC drugs slackening in many markets due to price pressures from brick and mortar channels and as-yet slow uptick of sales via internet retailing. The market for vitamins and dietary supplements, on ...

Despite the ageing population, which could play in favour of sales of analgesics, the forecast period is expected to see a negative value CAGR at constant 2017 prices. There is some uncertainty regarding the performance of OTC products, including ...

Vitamin and dietary supplements (VDS) positioned as “immune boosters” or for “immune support” are very popular in the US market and growing more so, as consumers look to natural, preventive products to stave off seasonal colds and the flu. Loose ...

Analgesics is expected to record a relatively strong increase in sales over the forecast period, with growth rates set to be well in excess of what was recorded over the review period. Greater consumer confidence in OTC analgesics due to tighter ...

In 2017 analgesics experienced similar current value growth to 2016. The main story in 2017 was the launch of chewable ibuprofen targeted towards children. Due to the stagnant birth rate, the launch by GlaxoSmithKline Consumer Healthcare New Zealand ...

The Drug Regulatory Authority of Pakistan (DRAP) continued to maintain tight control over prices of analgesics during 2017 in order to ensure products in this area remain affordable for consumers within all income groups. However, at the same time, ...

The growth by topical analgesics continued to outpace systemic analgesics in 2017. Topical analgesics are popular in Singapore, especially among the elderly, as they provide direct relief to affected muscle group or joints. Demand was also driven by ...

Topical analgesics/anaesthetic recorded the strongest growth in analgesics in 2017. It is becoming a necessity which most households in Hong Kong carry for daily use. Growing demand amongst the older population contributed to the category’s ...

Ukrainians have developed a strong habit of alleviating different kinds of pain with the help of analgesics, finding this effective and convenient, while not making visits to doctors until health problems become serious. This trend will continue to ...

Analgesics, like most other OTC formats, seemed to be slowing at the end of the review period. Maturation is clearly the underlying trend, although sluggish value performance in 2016 and 2017 was also due to the declines in retail prices in 2016 and ...

Analgesics saw slower current value growth in 2017 compared to the CAGR seen over the review period, which was a consequence of the increasing presence of generic products with lower prices. In addition, due to this, established companies limited ...

Despite the maturing of analgesics, players continue to effectively market their brands towards their target consumers. One of the growing target consumer groups is the increasing pool of young working people, who are not only driving growth in ...

Analgesics is mature in Guatemala, where population growth is the main driver of these products. Innovation is slow, as it takes time for new medicines to be developed or a new brand to gain brand recognition and fidelity, since consumers are worried...

In 2017, analgesics showed double-digit value growth and the category is expected to grow gradually by 2022. Undoubtedly, factors like population growth and a stable economy have a positive effect on overall demand for analgesics. However, in 2017 ...

Urbanisation, an increase in sports-related activities and the health and wellness trend continued to positively influence sales of analgesics in 2017. Topical analgesics/anaesthetic continued to see strong value sales growth due to the growing ...